Loading
institutionsInstitution
Japanese Society of Medical Oncology
Japan's medical oncology society, which certifies Japan's medical oncologists, holds a large annual meeting and publishes clinical guidelines with the Japan Society of Clinical Oncology.
Also called: JSMO日本臨床腫瘍学会
Overview
Founded in 2002 from the earlier Japanese Society of Medical Oncology study group, JSMO established medical oncology as a board-certified specialty in Japan and now has more than 10,000 members. Its annual meeting, held in English and Japanese, presents Japanese trial data and hosts joint sessions with ASCO, ESMO and the Korean and Chinese societies, and it publishes guidelines on cancer genomic profiling, molecular testing, febrile neutropenia and antiemetics together with the Japan Society of Clinical Oncology. JSMO has been central to Japan's national programme of comprehensive genomic profiling under public insurance and to the certification of core cancer genomic medicine hospitals.
Location
Tokyo, JP
Type
consortium
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#420 · 12 points (0 Newsweek + 0 NCI + 12 from 6 linked objects) · ranking
- Board certification of medical oncologists
- JSMO Annual Meeting
- Clinical guidelines (with JSCO)
- Cancer genomic medicine policy
Hidetoshi Hayashi
Vice-President
Thoracic oncologyLung cancerTargeted therapy
Vice-President of JSMO and thoracic medical oncologist at Kindai University known for clinical trials of targeted therapies in lung cancer.
Takayuki Yoshino
Chief, Department of Gastroenterology and GI Oncology, National Cancer Center Hospital East; President, Japanese Society of Medical Oncology
Colorectal cancerctDNA and molecular residual diseasePrecision oncology
Leads CIRCULATE-Japan, the largest ctDNA-guided adjuvant programme in colorectal cancer, and the PARADIGM and SCRUM-Japan GI efforts.
Yuichiro Ohe
Director, National Cancer Center Hospital; thoracic oncology
Lung cancerChemotherapyTargeted therapy
Thoracic oncologist who leads NCC Hospital in Tokyo and has been a Japanese principal investigator on a generation of lung cancer trials.
Similar pages
- PersonShunji Takahashi
Shares Cancer Institute Hospital of JFCR, Comprehensive genomic profiling.
- PersonHaruhiko Fukuda
Shares Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital.
- InstitutionNational Cancer Center Hospital East
Shares Takayuki Yoshino, Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital, Comprehensive genomic profiling.
- InstitutionKyushu University Hospital
Shares Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital, Comprehensive genomic profiling.
- InstitutionKyoto University Hospital
Shares Japanese oncology guidelines (JSMO, JSCO and organ societies), Japan Clinical Oncology Group (JCOG).
- PersonHitoshi Nakagama
Shares National Cancer Center Hospital, Comprehensive genomic profiling.
- IdeaMicro-learning pushed to community oncologists within 30 days of a practice change
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO).
- PersonTakashi Kohno
Shares National Cancer Center Hospital, Comprehensive genomic profiling.